全文获取类型
收费全文 | 1518639篇 |
免费 | 114265篇 |
国内免费 | 3055篇 |
专业分类
耳鼻咽喉 | 21514篇 |
儿科学 | 46914篇 |
妇产科学 | 41094篇 |
基础医学 | 226711篇 |
口腔科学 | 44031篇 |
临床医学 | 136051篇 |
内科学 | 286472篇 |
皮肤病学 | 32011篇 |
神经病学 | 116131篇 |
特种医学 | 58759篇 |
外国民族医学 | 243篇 |
外科学 | 232293篇 |
综合类 | 38159篇 |
现状与发展 | 3篇 |
一般理论 | 429篇 |
预防医学 | 116362篇 |
眼科学 | 35880篇 |
药学 | 115232篇 |
3篇 | |
中国医学 | 3816篇 |
肿瘤学 | 83851篇 |
出版年
2018年 | 15150篇 |
2016年 | 13153篇 |
2015年 | 15020篇 |
2014年 | 21014篇 |
2013年 | 31726篇 |
2012年 | 42547篇 |
2011年 | 44673篇 |
2010年 | 26250篇 |
2009年 | 24627篇 |
2008年 | 41795篇 |
2007年 | 45318篇 |
2006年 | 45368篇 |
2005年 | 43709篇 |
2004年 | 42733篇 |
2003年 | 40921篇 |
2002年 | 39556篇 |
2001年 | 68107篇 |
2000年 | 69435篇 |
1999年 | 58086篇 |
1998年 | 16512篇 |
1997年 | 14633篇 |
1996年 | 14790篇 |
1995年 | 13991篇 |
1994年 | 13230篇 |
1992年 | 47366篇 |
1991年 | 46717篇 |
1990年 | 45793篇 |
1989年 | 44714篇 |
1988年 | 41352篇 |
1987年 | 40351篇 |
1986年 | 38391篇 |
1985年 | 36800篇 |
1984年 | 27912篇 |
1983年 | 23794篇 |
1982年 | 14249篇 |
1981年 | 12946篇 |
1980年 | 12279篇 |
1979年 | 27167篇 |
1978年 | 19503篇 |
1977年 | 16480篇 |
1976年 | 15426篇 |
1975年 | 16819篇 |
1974年 | 20446篇 |
1973年 | 19547篇 |
1972年 | 18503篇 |
1971年 | 17220篇 |
1970年 | 16475篇 |
1969年 | 15714篇 |
1968年 | 14263篇 |
1967年 | 13031篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
995.
Cargill WH 《Journal of the National Medical Association》1940,32(4):155-161
996.
997.
998.
The aim was to determine whether the immunogenicity of an investigational hepatitis B vaccine (spHB) is at least as high as that of a licensed control vaccine, Engerix B®, and to evaluate its safety before inclusion in new pediatric combination vaccines. Two randomized, controlled, blind-observer, Phase 3 trials were performed: one in Argentina (344 participants aged 10–15 years, 10 μg HBsAg/dose) and one in Uruguay (344 participants aged 16–45 years, 20 μg HBsAg/dose). Both vaccines were given in a 0, 1, 6 month schedule to all participants with a baseline anti-Hep B antibody titer <0.6 mIU/mL. Antibody titers were measured pre-dose 1, 1 month after dose 2, pre-dose 3, and 1 month after dose 3. Statistical non-inferiority analyses were performed on seroprotection rates (SP) post-dose 3 (% with anti-Hep B titers ≥10 mIU/mL; delta non-inferiority limit of −10%). In both studies, SP for the spHB vaccine was 100% and the spHB vaccine was non-inferior in terms of SP to the licensed control vaccine. GMTs post-dose 3 were approximately 1.8- and 4.1-fold higher for spHB in the 10–15 year and 16–45 year age groups, respectively. Reactogenicity was low for each vaccine, after each dose. This highly immunogenic hepatitis B candidate vaccine was selected for further investigation as a component of new pediatric combination vaccines. 相似文献
999.
David Berrigan Linda W Pickle Jennifer Dill 《International journal of health geographics》2010,9(1):20
Background
Past studies of associations between measures of the built environment, particularly street connectivity, and active transportation (AT) or leisure walking/bicycling have largely failed to account for spatial autocorrelation of connectivity variables and have seldom examined both the propensity for AT and its duration in a coherent fashion. Such efforts could improve our understanding of the spatial and behavioral aspects of AT. We analyzed spatially identified data from Los Angeles and San Diego Counties collected as part of the 2001 California Health Interview Survey. 相似文献1000.
Reframing climate change as a public health issue: an exploratory study of public reactions 总被引:1,自引:0,他引:1
Edward W Maibach Matthew Nisbet Paula Baldwin Karen Akerlof Guoqing Diao 《BMC public health》2010,10(1):299